For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of NewAmsterdam Pharma Company NV (NASDAQ: NAMS) closed at $25.55 in the last session, down -1.88% from day before closing price of $26.04. In other words, the price has decreased by -$1.88 from its previous closing price. On the day, 0.65 million shares were traded. NAMS stock price reached its highest trading level at $26.35 during the session, while it also had its lowest trading level at $25.36.
Ratios:
We take a closer look at NAMS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.61 and its Current Ratio is at 10.61. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On March 14, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $35.Scotiabank initiated its Sector Outperform rating on March 14, 2024, with a $35 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 30 ’24 when ForGrowth NAP B.V. sold 29,846 shares for $25.54 per share. The transaction valued at 762,174 led to the insider holds 10,656,172 shares of the business.
ForGrowth NAP B.V. sold 41,472 shares of NAMS for $1,076,290 on Dec 27 ’24. The 10% Owner now owns 10,686,018 shares after completing the transaction at $25.95 per share. On Dec 26 ’24, another insider, ForGrowth NAP B.V., who serves as the 10% Owner of the company, sold 33,438 shares for $26.01 each. As a result, the insider received 869,629 and left with 10,727,490 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAMS now has a Market Capitalization of 2735204096 and an Enterprise Value of 1938236032. Its current Enterprise Value per Revenue stands at 57.696 whereas that against EBITDA is -10.531.
Stock Price History:
Over the past 52 weeks, NAMS has reached a high of $27.29, while it has fallen to a 52-week low of $11.95. The 50-Day Moving Average of the stock is 12.21%, while the 200-Day Moving Average is calculated to be 29.32%.
Shares Statistics:
According to the various share statistics, NAMS traded on average about 767.90K shares per day over the past 3-months and 486300 shares per day over the past 10 days. A total of 92.17M shares are outstanding, with a floating share count of 50.57M. Insiders hold about 52.66% of the company’s shares, while institutions hold 35.57% stake in the company. Shares short for NAMS as of 1734048000 were 2584311 with a Short Ratio of 3.37, compared to 1731628800 on 1008065. Therefore, it implies a Short% of Shares Outstanding of 2584311 and a Short% of Float of 3.6799999999999997.
